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Nonvaccine interventions have proven
unreliable in the control of adenovirus-
associated acute respiratory disease (1). Before
live, oral, enteric-coated adenovirus types 4 and
7 vaccines were introduced in 1971, adenovirus-
associated acute respiratory disease produced
high attack rates and excessive illness in soldiers
during service-entry basic combat training (2).
The subsequent policy to vaccinate all male
trainees during basic combat training drastically
reduced adenovirus type 4- and type 7-associated
acute respiratory disease (3).
In 1996, the sole manufacturer of the
vaccines ceased production (4). To conserve the
remaining vaccine lots, the army  restricted use
of adenovirus vaccines to the period of
September 1 through March 31, the peak season
for acute respiratory disease. Administration of
adenovirus vaccines to military trainees was
suspended on March 31, 1997, at all army basic
training centers. To monitor the impact of this
modified policy, intensive, laboratory-based
surveillance was initiated in late April 1997 at
Fort Jackson, South Carolina, the army’s largest
basic combat training center. An epidemic of
adenovirus type 4-associated acute respiratory
disease occurred among male and female soldiers
in basic combat training at Fort Jackson after the
vaccination was suspended. The first case
appeared in late May, and the outbreak lasted
until December, after vaccination was resumed
in November.
The Outbreak
During May through December 1997, a
monthly average of 6,847 soldiers from all
geographic regions of the United States and its
protectorates were engaged in the 8-week basic
combat training program at Fort Jackson.
During this period, 38.2% of the trainees were
women. The mean age of soldiers enrolled in this
study was 19.7 years.
All trainees who report to sick call with fever
of 100.5° F or higher are admitted to a minimal-
care hospital ward at the Fort Jackson Army
Hospital for observation and self-care. Soldiers
from this group who had an oral temperature of
100.5° F or higher, plus at least one sign or
symptom of an upper respiratory infection, were
enrolled in the surveillance program. Approxi-
mately 80% of soldiers hospitalized with acute
respiratory disease were enrolled since patients
admitted on weekends were not included. A
pharyngeal swab was taken from each trainee
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In May 1997, a large, persistent epidemic of adenovirus type 4-associated acute
respiratory disease began at Fort Jackson, South Carolina, the largest army basic
training center. The epidemic lasted until December and declined when vaccine
administration resumed. More than 1,000 male and female trainees were hospitalized;
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and immediately placed into virus transport
medium (Viromed Laboratories, Inc., Minneapo-
lis, MN). Specimens were stored at 2°C to 8°C for
an average of 72 hours before overnight
express shipment on wet ice to the laboratory
for virus isolation.
Virus isolations and identifications were
performed by the Department of Pathology
Laboratory at Dwight David Eisenhower Army
Medical Center. Adenoviruses were isolated in
human lung carcinoma (A-549) cells (Viromed
Laboratories, Inc., Minneapolis, MN). The
serotype of isolated adenoviruses was determined
by virus neutralization with type-specific antisera
(Centers for Disease Control and Prevention,
Atlanta, GA); the Reed-Muench method was used
for calculating the LD50 titer (5). Each culture
was also tested for influenza A and B;
parainfluenza 1, 2, and 3; herpes simplex virus;
and enteroviruses by cell culture, enzyme
immunoassay, and fluorescent antibody staining.
The first isolate of adenovirus type 4 came
from a patient who was hospitalized on May 22,
1997, approximately 7 weeks after administra-
tion of the adenovirus vaccines ended. During
May through December 1997, 1,018 basic
trainees whose illness met the case definition
were examined. Of these, 673 (66.1%) were
positive for adenovirus type 4. No other
respiratory disease agent was identified as an
important cause of illness in this epidemic. The
monthly case distribution was calculated by sex
for all hospitalized acute respiratory disease
patients (Figure 1) and for adenovirus type 4-
positive patients (Figure 2). Of the total acute
respiratory disease cases, 35.3% (only slightly
less than their representation in the total trainee
population of 38.2%) were in women. Similarly,
31.2% of all adenovirus type 4 isolates were from
women. During May, June, and July, the
monthly rates of acute respiratory disease
admissions were higher for women than for men
(Figure 1). These higher rates were not due to
adenovirus type 4 (Figure 2) or any other agent
tested for in this study.
The percentage of cases from which
adenovirus type 4 was isolated increased as the
epidemic progressed. At its peak, almost all
patients had an adenovirus type 4 isolate
(Figure 3). Isolation rates of more than 90% were
seen in both male and female patients toward the
end of the outbreak. At the peak of this epidemic,
Figure 1. Patients with acute respiratory disease, by
sex, May–December 1997, Fort Jackson, South
Carolina.
Figure 3. Percentage of total patients with acute
respiratory disease who also had an adenovirus type
4 isolate, May–December, 1997, Fort Jackson, South
Carolina.
Figure 2. Patients with adenovirus type 4-associated
acute respiratory disease, by sex, May–December
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approximately 70 soldiers per week were
hospitalized at Fort Jackson Army Hospital. This
corresponded to a weekly hospitalization rate for
the entire post of approximately 1.0 admission
per 100 soldiers. However, cases were not
uniformly distributed throughout the trainee
population but tended to occur in clusters. The
outbreak intensified until November 1997, when
the adenovirus vaccines were reintroduced.
(Vaccination was to resume on September 1,
1997, according to the modified army policy.
However, the vaccines did not reach Fort
Jackson until November.) Resumption of
adenovirus immunizations was associated with a
rapid decline in both new cases of acute
respiratory disease and isolations of adenovirus
type 4. The last isolate of adenovirus type 4 was
seen in December 1997. No additional isolates
were reported during January through April
1998, except for a single isolate in a vaccinated
trainee in February 1998. Administration of
adenovirus types 4 and 7 vaccines continued
through March 31, 1998.
Conclusions
Traditionally, adenovirus vaccines were
administered to male trainees entering basic
combat training between October and April, but
outbreaks due to types 4 and 7 occurred in the
absence of vaccines. The year-round use of the
two vaccines beginning in 1984 resulted in the
elimination of outbreaks due to both the type 4
and type 7 viruses (3).
In 1994, administration of the vaccines was
temporarily interrupted, and a limited outbreak
occurred among male and female basic trainees
at Fort Jackson (6). This outbreak, which began
in 1995 approximately 5 to 6 weeks after the
administration of the adenovirus vaccines was
reinstated, was centered in one military unit
that had not received the vaccines; the outbreak
lasted only a few weeks, probably because the
pool of susceptible soldiers was small. Concern
about the threat of adenoviruses was validated
by serologic data, which revealed that the
adenoviral susceptibility of personnel entering
the military in the 1990s was similar to that of
personnel who entered in the 1970s (4).
The temporal relationship of this epidemic to
suspension of adenovirus vaccination in March
1997 demonstrates the effectiveness of type-
specific vaccine in controlling and preventing
military epidemics. Trainees began and ended
the 8-week basic combat training program each
week, so it would take approximately 2 months
for all trainees who received the vaccines to
complete basic combat training and leave Fort
Jackson. The first case of adenovirus type 4-
associated acute respiratory disease occurred in
May, approximately 7 weeks after vaccination
was suspended. The epidemic continued until
December 1997, when it was interrupted by the
administration of adenovirus types 4 and 7
vaccines to all new soldiers and to all soldiers
(men and women) already enrolled in basic
combat training at Fort Jackson. The army
hospital managed the acute respiratory
disease patient workload during the 1997
epidemic, but the unexpected inpatient census
proved stressful for staff and facilities.
When men and women had separate basic
combat training programs, adenovirus-associ-
ated acute respiratory disease outbreaks were
never documented in women, and the adenovi-
rus vaccines were not administered to women
(2,4). When the gender-integrated program
started at Fort Jackson approximately 5 years
ago, the decision was made to continue providing
the vaccine only to men. In the limited
adenovirus type 4-associated acute respiratory
disease outbreak at Fort Jackson in 1995, women
were hospitalized and had adenovirus type 4
isolated (6). During this large 1997 epidemic,
women and men in the integrated basic combat
training program were similarly affected by
adenovirus type 4-associated acute respiratory
disease. Early in this outbreak, admission rates
for acute respiratory disease were higher in
women. However, an etiologic agent was not
identified. Acute respiratory disease in women in
integrated basic combat training programs
cannot be assumed to be the same as that
observed in men and must be studied further.
Historically, adenovirus types 4 and 7 have
been the major causes of acute respiratory
disease in the military (2). We cannot state why
type 4 caused this outbreak rather than type 7.
However, documented military outbreaks dem-
onstrate that both vaccines are necessary, since
prevention of type 4-associated acute respiratory
disease alone will result in the emergence of type
7-associated disease (2).
This epidemic demonstrates that adenovirus
type 4 is a major threat to both male and female
soldiers in basic combat training. Additionally, it
confirms that large outbreaks due to adenoviruses801 801 801 801 801 Vol. 5, No. 6, November–December 1999 Emerging Infectious Diseases
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should be expected in unvaccinated basic combat
trainees.
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